APA

Rajagopalan S., Olin J. W., Young S., Erikson M., Grossman P. M., Mendelsohn F. O., Regensteiner J. G., Hiatt W. R. & Annex B. H. (20041216). Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease. : Human gene therapy.

Chicago

Rajagopalan Sanjay, Olin Jeffrey W, Young Stuart, Erikson Marlena, Grossman Paul M, Mendelsohn Farrell O, Regensteiner Judith G, Hiatt William R and Annex Brian H. 20041216. Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease. : Human gene therapy.

Harvard

Rajagopalan S., Olin J. W., Young S., Erikson M., Grossman P. M., Mendelsohn F. O., Regensteiner J. G., Hiatt W. R. and Annex B. H. (20041216). Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease. : Human gene therapy.

MLA

Rajagopalan Sanjay, Olin Jeffrey W, Young Stuart, Erikson Marlena, Grossman Paul M, Mendelsohn Farrell O, Regensteiner Judith G, Hiatt William R and Annex Brian H. Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease. : Human gene therapy. 20041216.